Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Description of key information
In accordance with REACH Article 18, testing is not required for this type of submission. 
Classification and labelling are based on negative i) in vitro screening bioassays in human embryonic stem cells (Klimisch 2) and ii) a TOPKAT QSAR modelling .
Effect on fertility: via oral route
Endpoint conclusion:
no study available
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

In accordance with REACH Article 18, testing is not required for this type of submission.


Short description of key information:
In accordance with REACH Article 18, testing is not required for this type of submission.

Effects on developmental toxicity

Description of key information
In accordance with REACH Article 18, testing is not required for this type of submission.
Effect on developmental toxicity: via oral route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

In accordance with REACH Article 18, testing is not required for this type of submission.

Toxicity to reproduction: other studies

Additional information

An in vitro human embryonic stem based devTOX Discovery assay and associated statistical models (metabolomics) were applied for predicting the potential for developmental toxicity. Exposure to bis(2-ethylhexyl) citraconate was made for three treatment levels (3, 30, and 300 μM). Based on these data, the compound did not show metabolic perturbation indicative of the potential to exhibit teratogenicity over the exposure range studied. In addition, the compound showed no cytotoxcity over the exposure range tested in either the dose ranging or metabolomics portions of the study. Only two significantly changed mass features were detected when treated cells were compared with DMSO controls, further indicating the compound exerts little impact on the growth and metabolism of hES cells. The study was conducted in accordance with Stemina's Standard Operating Procedures under non-GLP (non applicable OECD or EU test methods were yet available). The results are rated as Klimisch 2 and used as weight of evidence for classification and labelling and PBT assessment.

The extended TOPKAT QSAR model predicts the developmental toxicity potential of the test substance as negative with moderate confidence. An external expert assessment verifies that the 5 OECD principles for QSAR models validation are met. The prediction is therefore considered as Klimisch 2 and used as weight of evidence for classification and labelling and PBT assessment.

Conclusion:

Based on negative weight of evidence from in vitro screening assays on human embryonic cells and TOPKAT modelling results, there are no indications of reproductive toxicity of bis(2 -ethylhexyl)citraconate to humans.

Justification for classification or non-classification

In accordance with REACH Article 18, testing is not required for this type of submission.

Non-classification and labelling are based on negative weight of evidence from in vitro metabolomics study on human embryonic stem cells and TOPKAT QSAR modelling.

Additional information